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ABSTRACT Cholera toxin (CTx) is an AB5 cytotonic protein that has medical relevance in cholera and as a novel mucosal
adjuvant. Here, we report an analysis of the noncovalent homopentameric complex of CTx B chain (CTx B5) using electrospray
ionization triple quadrupole mass spectrometry and tandem mass spectrometry and the analysis of the noncovalent hexameric
holotoxin usingelectrospray ionization time-of-ﬂight mass spectrometry over a range of pH values that correlate with those
encountered by this toxin after cellular uptake. We show that noncovalent interactions within the toxin assemblies were main-
tained under both acidic and neutral conditions in the gas phase. However, unlike the related Escherichia coli Shiga-like toxin B5
pentamer (SLTx B), the CTx B5 pentamer was stable at low pH, indicating that additional interactions must be present within the
latter. Structural comparison of the CTx B monomer interface reveals an additional a-helix that is absent in the SLTx B monomer.
In silico energy calculations support interactions between this helix and the adjacent monomer. These data provide insight into
the apparent stabilization of CTx B relative to SLTx B.
INTRODUCTION
Cholera toxin (CTx), produced by toxinogenic strains of
Vibrio cholerae, is a heterohexameric AB5 protein belonging
to the family of related toxins that are associated with human
disease. Infection with V. cholerae can lead to an acute gas-
trointestinal disease resulting in toxemia and chronic diar-
rhea causing the loss of over 10–20 liters of body ﬂuids per
day in some cases (1) and frequently resulting in a mortality
of 20–50% in untreated cases (2,3). Indeed, there are over
200,000 reported new cases of cholera each year (4). CTx,
the main toxic product produced during infection, has been
characterized, alongwith the producing bacterium, as a poten-
tial ‘biowarfare’ agent by the US and UK defense agencies
(5). The structure of CTx holotoxin and the CTx B pentameric
subunits have been determined by means of x-ray crystal-
lography (6–8). These studies revealed that the ﬁve B sub-
units (;11.6 kDa/subunit) form a doughnut-shaped ring and
that the A subunit (;27.5 kDa) is composed of two distinct
domains, A1 and A2. The A1-domain is responsible for the
enzymatic activity of the toxin, whereas the A2-domain
assists in the tethering of the A1-domian to the B subunit
pentamer by inserting noncovalently into and through the
central pore of the B5 complex (Fig. 1). The CTx A1 subunit
is an ADP-ribosyltransferase and NAD-glycohydrolase that
can modify G proteins by ADP ribosylation (9). The main
intracellular target of CTx directly associated with the
induction of ﬂuid secretion is Gs, a G protein involved in the
activation of the adenylate cyclase complex (10–12), al-
though the toxin can affect numerous metabolic processes
through the modiﬁcation of other G proteins. Modiﬁcation of
Gs by CTx leads to constitutive activation of the adenylate
cyclase complex and elevated intracellular cAMP levels
(13–15), which in turn stimulates active chloride secretion
(16–18) resulting in a severe form of secretory diarrhea.
To accomplish these intracellular changes, CTxmust reach
the cytosol of its target cells. CTx binds, via its B pentamer,
to the glycosphingolipid GM1 ganglioside (19–21), which is
present in the plasma membrane of virtually all cell types,
including those cells that line the intestinal tract and certain
cells associated with the control and function of the immune
system (22). Binding of CTx to GM1 at the plasma mem-
brane triggers toxin uptake and subsequent retrograde delivery
of the toxin to the endoplasmic reticulum (ER) (23–28) where
the A1-domain is reduced from the A2-B5 complex and then
retrotranslocated across the ER membrane into the target cell
cytosol where it can modify its targets (27,29–32).
In addition to the well-characterized cytotonic properties
of CTx, interaction between the CTx holotoxin or the isolated
B5 pentamer and speciﬁc target cells can also promote sig-
naling pathways not linked to cAMP induction or indeed to
other second messenger molecules. This can lead to different
immunomodulatory functions, such as mucosal adjuvant
effects, depending on the target cell type (22). A key element
in the diverse signaling activities of this toxin is the initial
oligomerization of GM1 receptors upon binding the B-chain
pentamer. This is believed to promote the recruitment of both
signaling and accessory molecules into cholesterol-enriched
membrane microdomains (lipid rafts) to establish and enhance
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signaling cascades (22,33). As such, analysis of the noncovalent
interactions that promote and maintain the quaternary struc-
ture of this toxin is of fundamental importance since such inter-
actions have signiﬁcant biochemical andmedical implications.
There have been relatively few reports of the analysis of
CTx by mass spectrometry (MS) (34,35). An in-depth study
by liquid chromatography MS (LC-MS) and LC tandem MS
(LC-MS/MS) provided sequence information derived from
tryptic digestion and showed that the toxin was well suited to
mass spectrometric detection (35). During this previous inves-
tigation, the AB5 holotoxin was not detected. Here, we
demonstrate that the complete noncovalent assembled AB5
holotoxin remains intact during the electrospray ionization
(ESI) process and can be observed in the mass spectrum.
ESI-MS has been shown to be an extremely useful tool in
the study of the AB5 noncovalent assemblies of the Shiga-
like toxin (SLTx) and multivalent complexes of SLTx with
globotriaoside (36). We have previously shown that SLTx
from Escherichia coli can be detected over a pH range of 3–7
(37), in contrast to the previous studywhere the AB5 holotoxin
was not detected at neutral pH (36). Investigation of the dis-
sociation of the homopentamer B5, B4, and B3 assemblies
by collision-induced dissociation (CID) in an instrument capa-
ble of performing MS/MS experiments was shown to pro-
vide dissociation pathways of the assemblies. Information
relating to the structure of the assemblies was inferred from
the product ions formed from the MS/MS experiments. The
results obtained for the dissociation of the homopentamer
B5 during the previous study (37) were consistent with those
obtained by thermal decomposition by blackbody infrared
radiative dissociation within the cell of a Fourier transform
ion cyclotron resonance mass spectrometer (38).
Here, ESI-MS and ESI-MS/MS have been successfully
used to examine the noncovalent interactions that exist
between the subunits of the complete CTx holotoxin and the
pentameric B chains. The ﬁrst objective of this investigation
was to examine the ions produced from the complete hexameric
noncovalent holotoxin complex (CTxAB5).Our results clearly
show that the intact complex was observed in the gas phase
in a time-of-ﬂight (TOF) mass spectrometer. Furthermore,
we report the dissociation of the noncovalent homopenta-
meric binding subunit of the CTx by means of CID in a
collision cell of a triple quadrupole mass spectrometer. This
has allowed us to probe the noncovalent assembly of CTx
and CTx-B5s through their gas phase dissociation pathways.
MATERIALS AND METHODS
CTx and CTx B-subunit were purchased from Sigma (St. Louis, MO). The
toxin samples were extensively dialyzed against 10 mM ammonium acetate
(Sigma) at pH 7.0, desalted using PD-10 gel ﬁltration columns, and con-
centrated to a ﬁnal protein concentration of 16.3 mM for CTx holotoxin and
8.97 mM for CTx B in a Centricon 10 apparatus (Millipore, Watford, UK).
Mass spectrometry
Experiments were performed in a single TOF mass spectrometer (LCT,
Waters MS Technologies, Manchester, UK) and a triple quadrupole mass
spectrometer (QuattroUltima,Manchester, UK). In each instrument, noncovalent
assemblies were observed by increasing the backing pressure between the
source and high vacuum region. Both instruments were equipped with the
standard Z-spray ESI source and operated at a source and desolvation tem-
perature of 110C. Sample solutions were introduced into the source region
of the instruments by conventional electrospray, operated in positive mode
of ionization with a capillary voltage of 3 kV, and optimized for the trans-
mission of noncovalent assemblies. In the triple quadrupole instrument, tandem
mass spectrometry (MS/MS or MS2) was carried out using argon collision gas
at a pressure of 2.5 3 103 mbar within the radio-frequency (RF)-only
hexapole collision cell.
Data acquisition and processing were carried out usingMassLynx (V3.5).
Transform or, alternatively, maximum entropy-based software was used to
ﬁnd the masses of the subunits and hence the charges on each multiply
FIGURE 1 Crystal structure of CTx and the CTx B5 pentamer. (A) CTx
holotoxin viewed sideways with the surface of the B pentamer that contains
the GM1 binding sites facing downward. The catalytic A chain showing
secondary structure. The A2 fragment can be seen to insert into the core of
the B pentamer. (B) CTx B5 pentamer shown from the top, with a single
monomer indicated.
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charged ion. All spectra shown were subjected to minimal smoothing. The
upper m/z range of the triple quadrupole instrument is 4000 so that, since
the monomer has a mass of nearly 11,600, ions of the type By1x could
be observed only if y is 3x or greater.
The complex formed by the homopentameric binding subunit of the CTx
(CTx B5) and the hexameric holotoxin (CTx AB5) was studied by direct
infusion at a concentration of 4.5 pmol/mL and 8 pmol/mL in 10mM aqueous
ammonium acetate at a pH of 4.0–7.0, adjusted by addition of dilute ammonia
or formic acid solution, respectively. A Harvard Apparatus (South Natick,
MA) Model 22 syringe pump was used to provide a ﬂow rate of 4 mL/min.
Molecular modeling
The structures of SLTx (PDB code 1BOV) and CTx B (PDB code 1FGB)
were taken from the Protein Data Bank (PDB) at Brookhaven (39) and
imported into the Molsoft ICM program (40). The coordinates of the struc-
tures were then converted into internal coordinate space to allow regular-
ization of the structures to be performed. Interchain energy calculations were
made using the standard ICM force ﬁeld (40) between two adjacent mono-
mers (chains A and B in 1BOV and chains D and E in 1FGB). Interactions
were speciﬁcally analyzed and images made using ICM.
RESULTS AND DISCUSSION
Triple quadrupole MS for the AB5 holotoxin
Initially, the CTx holotoxin (4 pmol/mL) was analyzed
denatured in a solution of acetonitrile/H2O 1 0.2% formic
acid. This conﬁrmed the homogeneity of the CTx B compo-
nents. However, the CTx A protein was heterogeneous and
consisted of two components (Fig. 2). Maximum entropy
provided the average molecular mass of 11605.2 Da for the
CTx B subunit and average molecular masses of 26581.4 Da
and 26905.8 Da for the heterogeneous CTx A protein. The
maximum entropy deconvoluted spectrum obtained clearly
identiﬁes two different major components for the A protein
(Fig. 2 B).
The A-subunit consists of two chains, A1 (194 residues)
and A2 (46 residues) which are connected by a disulphide
bridge, whereas the B chain (103 residues) is a single poly-
peptide (Fig. 3 A). The heterogeneity observed within the
A chains of these family of proteins is not uncommon, as
previously reported for the related AB5 protein, SLTx (37).
The average mass observed at 26905.8 Da for CTx A chain
is identical to one observed previously (35) and has been
ascribed to the loss of methionine from the N-terminal of the
A2 chain together with the loss of two serine residues from
the C-terminus of the A1 chain (Fig. 3 B). The average mass
difference between the observed and predicted mass of
26904.8 Da is 41 parts-per-million (ppm). The peak at
26581.4 Da was not previously observed and probably
corresponds to the loss of methionine from the N-terminus of
the A2 chain together with the loss of two serine residues,
arginine, proline, and alanine from the C-terminus of the A1
chain (Fig. 3 C). Again the average mass difference between
the observed and predicted mass of 26580.3 Da is 41 ppm.
The difference between the predicted and observed mass was
extremely low in both cases, conferring a high degree of
conﬁdence in the predicted cleavage patterns. Although the
masses agree well with theory, this does not necessarily
negate the need to determine the exact sequences for samples
in which the origin is not precisely known. However, in this
case, the samples were obtained from a commercial source
and the full amino acid sequence of the A1, A2, and the B
chains is well established (35). It is conceivable that during
the periplasmic expression of CTx the A1 and A2 chains are
partially trimmed at either or both termini, thus generating
FIGURE 2 ESI-triple quadrupole mass spectrum of the denatured cholera
holotoxin at a concentration of 4 pmol/mL in acetonitrile/H2O1 0.2% formic
acid (A). Maximum entropy deconvoluted spectrum expanded in the region
from m/z 10,000 to 30,000 highlighting the heterogeneity of the A unit (B).
FIGURE 3 Schematic representation of the CTx holotoxin, with the
amino acid residues at the amino (N) and carboxyl (C) termini of the A1, A2,
and B chains indicated. Shown is the complete CTx holotoxin (A), along
with the two predicted cleavage products (B and C).
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smaller polypeptide chains, similar to that reported previ-
ously for the related SLTx A chain (37).
TOFMS for the AB5 holotoxin
ESI-TOFMS was used to try to observe the complete
noncovalent CTx AB5 complex in the gas phase. Abundant
ions were observed for the B subunit monomer and the B5
pentamer, with less abundant ions observed for the AB5
holotoxin ions at pH 7.0 (Fig. 4 A). The base peak in the mass
spectrum corresponds to the monomer B71. The partial mass
spectrum has been expanded in the region m/z 3000–5000
(Fig. 4 B). The abundances of the B5 pentamer and the AB5
holotoxin ions remained in fairly constant ratio over the pH
range 4.0–7.0 under the condition speciﬁed (partial mass
spectrum obtained at pH; 4.0; Fig. 4 C). The abundances of
the monomer and pentamer ions observed did not remain
constant over the pH range. At pH 5.0 the monomer B71 ion
had a relative abundance of ;93% of the base peak corre-
sponding to the pentamer B1715 ion. At pH 4.0, the monomer
B71 ion was observed in the mass spectrum as the base peak
and the pentamer B1715 ion had a relative abundance of
;64% to the monomer B71 ion. The observed charged states
for the AB5 holotoxin extend from 21
1 to 151. It is of
interest to note that both the AB5 and B5 ions were observed
throughout the pH range examined, suggesting that the
hexameric AB5 CTx assembly and the pentameric B5 CTx B
assembly were both stable at acidic pH. This is in marked
contrast to ﬁndings with the structurally related AB5 SLTx,
where the cell-binding B5 pentamer was less stable at acidic
pH than the complete AB5 holotoxin (37). We therefore sug-
gest that the presence of the A2 portion of CTx A chain is not
required to stabilize the CTx B pentamer in the gas phase, as
has been postulated for SLTx (37,41,42), but rather that sta-
bility arises from the inherent properties of the CTx-B5. This
is consistent with the known stability of CTx B in aqueous
solution (6,7,43) where the presence of the A chain had little
effect on the stability of the B pentamer.
The heterogeneity of the CTx A chain observed in the
triple quadrupole MS was further examined by TOFMS
under conditions that maintained the noncovalently associ-
ated holotoxin intact in the gas phase. Transformation of the
spectrum in the region of m/z 3000–5000, which corre-
sponds to the ions observed for the AB5 holotoxin, gave sug-
gested molecular mass of 84612.8 Da (calculated 84608.1
Da) and 84932.4 Da (calculated 84932.3 Da) for the het-
erogeneous AB5 holotoxin. The results obtained demonstrate
that the masses are in good agreement with those expected
for the hexameric complex, calculated previously from the
denatured complex (Fig. 2).
We have demonstrated that the complete noncovalent
assembly of the CTx holotoxin can be detected by ESI-
TOFMSover a range of physiological pHs. To our knowledge,
this is the ﬁrst time the CTx holotoxin assembly has been
observed intact in the gas phase by MS. The increased
sensitivity afforded by TOF mass analyzers for observing
FIGURE 4 ESI-ToF mass spectra
obtained for the AB5 cholera holotoxin
buffered with ammonium acetate at
pH ; 7.0 (A). Also shown is the non-
covalent assembly at pH 7.0 expanded
in the region m/z 3000–4500 (B) and
the noncovalent assembly at pH 4.0 ex-
panded in the region m/z 3000–4500 (C).
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such AB5 assemblies intact in the gas phase supports and
extends our previous work (37). The high degree of sensi-
tivity also allowed for the accurate detection of differentially
trimmed species of the A-chain component of the holotoxin
preparation. Over 2 min acquisition time at a ﬂow rate of
4 mL/min, 8 mL of 8 pmol/mL of AB5 solution was con-
sumed to generate the mass spectra shown.
The TOF instrument is not capable of MS/MS experi-
ments and further investigative studies were performed in a
triple quadrupole instrument. The CTx AB5 ions observed
could not be subjected to MS/MS experiments because of the
upper mass range of 4000 of the triple quadrupole instru-
ment. Therefore, further MS/MS experiments were carried
out solely on the CTx B5 pentamer.
Triple quadrupole MS for the homopentamer B5
The CTx pentamer B5 consists of ﬁve identical subunits that
arrange into a pentameric ring structure (Fig. 1 B). Each
subunit has a molecular mass of 11.6 kDa and is composed
of 103 amino acids. Initially, the mass spectrumwas obtained
for the noncovalent complex of CTx B5 buffered with
ammonium acetate at pH ; 6.6 (Fig. 5). Ions corresponding
to the CTx B5 homopentamer were observed at a range of pH
from ;4.0–7.0 (data not shown). The mass spectrum was
obtained with a declustering voltage of 60 V. The base peak
in the mass spectrum corresponds to B1615 . The dominant
signal corresponds to the intact homopentamer (B5), with
observed charge states extending from 181 to 151. The
pattern of abundance of these ions is identical to the multiply
charged species observed with the SLTx B5 ions, which
extended from 151 to 121 (37). This presumably reﬂects
the overall similarity in tertiary and quaternary structure
between the two toxins. The mass spectrum also shows mono-
mer ions (B) with observed charge states from 81 to 51. The
mass spectrum demonstrates that the homopentamer B5, the
dominant quaternary form of the B subunit protein in solu-
tion (44–46), remains intact during the ESI process. Further-
more, the B5 complex remained intact over a range a pH.
Over 3 min acquisition time, at a ﬂow rate of 4 mL/min,
12 mL of 4.5 pmol/mL of B5 solution was consumed to
generate the mass spectra shown.
It has been reported that low pH (;5.0), similar to that
found within the endosome compartment of intoxicated
target cells, causes a conformational change within the CTx
B5s (47,48). However, this conformational change did not
promote bound CTx B to dissociate from the GM1 receptor,
but rather caused speciﬁc changes that affected the structure
of the interface between the protein and the membrane to
which CTx B was bound (47). If we presume that under our
experimental conditions CTx B undergoes a similar struc-
tural alteration, we would not predict a destabilization of the
B5 pentameric assembly in the gas phase. Given that the
GM1 binding site, as revealed by the crystal structure, is
formed between two adjacent monomers, our data are com-
pletely consistent with this, insofar as low pH does not alter
the binding of CTx to GM1 (47) or, as reported here, does
not destabilize the noncovalent CTx B-pentamer.
Triple quadrupole MS/MS of the homopentamer B5
MS/MS was then used to investigate the dissociation path-
way of the homopentamer B1715 ion (Fig. 6). The two dominant
ions in the mass spectrum of the homopentamer correspond
to B1615 and B
171
5 (Fig. 5). The B
171
5 ion was selected as a
precursor ion to undergo CID in the collision cell of the
FIGURE 5 ESI-triple quadrupole mass spectrum of the noncovalent
complex of CTx-B5 at pH 6.6.
FIGURE 6 ESI-Triple quadrupole MS/MS mass spectra of the non-
covalent complex of CT-B5. Shown is the dissociation obtained at a collision
energy of 15 eV (A) and 45 eV (B) for the precursor ion B1715 . Shown is the
possible dissociation pathway for the B1715 ion (C).
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instrument, the collision energy being varied (15–45 eV
(ELAB ¼ 255–765 eV)) to obtain intense fragment ions
(product ions). An increase in the abundance of product ions
was observed as the collision energy was increased (Fig. 6
B). The multiply protonated pentamer species B1715 selected
for CID dissociates almost entirely via the loss of one subunit
(Fig. 6 B) to form primarily abundant monomer ions having a
range of charges. A very low abundant dimer B712 ion is also
observed. The B1715 dissociation formed monomer, dimer,
trimer, and tetramer ions, but no peaks which could be unequiv-
ocally assigned to trimer ions were observed. These ions
could still be formed, however, as the ions B313 , B
61
3 , and
B913 cannot be distinguished from the ions B
1, B21, and
B31, B212 , B
41
2 , and B
61
2 , and B
41
4 , B
81
4 , and B
121
4 ,
respectively, to which some of the peaks have been assigned.
However, not all of the ions that are predicted to form were
detected (Fig. 6 C). This was either due to them being present
in very low abundance or due to the m/z ratio of the ion being
beyond the upper m/z range of the instrument, 4000, as dis-
cussed above. This is important since the pentamer ion
selected for dissociation does not only form monomer ions
with a range of charges, it must form tetramer ions with a
range of charges also. The tetramer ions formed though, for
example B1014 , will unfortunately not be detected due to the
limited m/z range of the instrument.
The dissociation of 50% of the CTx precursor ion B1715
required a collision energy of 40 eV, (ELAB 680 eV) ;2.4-
fold higher than that seen for the SLTx precursor ions B1415
(Fig. 7) and B1315 (37), which both showed 50% dissociation
of the precursor ions at ;20 eV (ELAB 280 eV).
A rough comparison of the relative stability of the two
complexes may be gained from a comparison of the relative
collision energies required to reduce the intensities of the two
precursor ions, B1715 (CTx) and B
141
5 (SLTx), to 50% of their
initial abundances at similar collision gas pressures. An exact
comparison cannot be made since the ions carry different
numbers of charges and the distribution of products is
unknown in each case. For the CTx complex, a 50% reduc-
tion in the abundance of the B1715 ion was observed when a
potential difference of 40 V was applied between the source
and the RF-only collision cell, corresponding to a laboratory
collision energy, ELAB, of 17 3 40 ¼ 680 eV. For the SLTx
complex, a similar reduction in the abundance of the B1415
ion was observed with a potential difference of 20 V, corre-
sponding to a laboratory collision energy, ELAB, of 143 20¼
280 eV. The approximate masses of the two complexes are
58 kDa and 38 kDa, respectively, and the collision gas was
argon, mass 40 Da. The amount of energy available to effect
dissociation, the center-of-mass collision energy ECOM, is
given by ECOM ¼ ELAB 3 (mAr/(mAr 1 mion)) 3 96.5 kJ
mol1, where ELAB is the ion kinetic energy in the laboratory
frame of reference, mAr is the mass of argon the collision cell
gas, and mion is the mass of the precursor ion. This leads to
values of ;45 kJ mol1 and 28 kJ mol1 for the CTx and
SLTx complexes, respectively, implying that ;1.5 times as
much energy is required to effect the dissociation of the CTx
pentamer compared to the SLTx B complex.
This difference in pentamer stability is also seen in aque-
ous solution (44,46,49). Despite these differences, a high
degree of structural stability exists in both the CTx and SLTx
B5 pentamers at physiological pH (37). This has been attrib-
uted to the large number of intersubunit interactions that
occur between monomers (6,50). The amount of surface area
buried during pentamer assembly differs between the two
toxins, with CTx B having a greater buried surface area
(2700 A2) than SLTx B (.1269 A2 , 2700 A2) (6,51). The
degree of buried surface area correlates well with the mea-
sured stabilities of the two pentamers (44), implying that
additional interactions must be present within the CTx B
monomer-monomer interface to account for its increased sta-
bility. We therefore compared the monomer interface region
in the two different pentameric proteins. This revealed that
the CTx B monomer interface has an additional a-helix
which lies in front of the continuous b-sheet that forms the
majority of the CTx B monomer interactions (Fig. 8 A) and
this region of secondary structure contains residues that inter-
act with residues that lie in the adjacent monomer. The SLTx
B monomer interface region, however, possesses only the
continuous b-sheet structure and not the a-helix (Fig. 8 B).
In silico energy calculations were performed using the
crystal structures of the CTx B (PDB code 1FGB) and SLTx
B (PBD code 1BOV) pentamers to assess the theoretical
interactions that exist between the additional helix present in
the CTx B structure that can interact with the adjacent mono-
mer (Table 1). The comparison of the pentameric structures
provides an insight into the apparent stabilization of CTx B
relative to SLTx B. The additional N-terminal helix shown
in the CTx B structure is involved in a number of extra in-
teractions between monomers such that the intermonomer
FIGURE 7 Plot of the relative ion intensity for the SLTx B1145 ion (open
symbols) and the CTx B1175 ion (solid symbols) versus the collision energy
(eV) applied to the ions. The amplitudes of the energy of the two curves at
50% of the intensity provide a measure of the relative gas phase stability
of the complexes.
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interaction energy is;2.4 times greater thanbetween themono-
mers of SLTx B. This value is in agreement with that deter-
mined experimentally for the increase in energy required to
dissociate the two complexes. This revealed that the additional
interactions in the CTx B pentamer would most likely result
in an increased degree of stability of ;236 kJ mol1 to this
molecule compared to the SLTx B pentamer. Although the
gas phase experimentally determined values are much lower
than the theoretically calculated values of 405.7 and 169.5 kJ
mol1, respectively, formonomer-monomer interactions (Table
1), this is to be expected because of the contribution of cou-
lombic repulsion in the fragmenting of the highly charged
complexes. The gas phase stability calculation assumes that a
single collision has occurred to the precursor ion; however as
is the case for large complexes studied here, to reduce the
precursor ion intensity by 50%, multiple collisions will occur
and contribute to the ECOM value. As gas phase complexes
are desolvated before mass analysis, the hydrogen bonding
and electrostatic interactions that survive ESI are possibly
accountable for maintaining the quaternary structure of the
desolvated complexes, whereas the hydrophobic interactions
may be lost or partially lost in the gas phase. As such, com-
plete correlation of gas phase and solution phase binding
energies would not be expected. Rather, the experimental and
theoretical results above show a similar trend, implying that
the dominant interactions stabilizing the quaternary structure
are maintained in the gas phase and can provide a rough
comparison to those in solution. The overwhelming majority
of the difference in energy can be accounted for by the pres-
ence of a strong hydrogen-bond interaction between E11 in
the ﬁrst monomer with R35 in the second (Fig. 8 C). Also
there is a signiﬁcant area of hydrophobic contact between the
N-terminal underside of the additional helix and the top of
the nearby sheet from the neighboring monomer (Fig. 8 C).
It is important to note that the N-terminal a-helix is held
in place by an intramolecular disulphide bridge (C9–C86),
which therefore helps to maintain a nonplastic surface for the
monomers to interact. We propose that although the interface
regions between adjacent monomers has a larger surface area
in the CTx B pentamer, the additional interactions present in
the CTx B helical region (residues 1–14) may provide the
increase in structural stability observed in both the gas and
aqueous phase. To further investigate these structural differ-
ences in the gas phase, a more detailed comparative study is
now required between different B5 pentamers.
CONCLUSIONS
As with all types of gas phase experiments, care must be
taken in the interpretation of the data, as normally the proteins
FIGURE 8 Crystal structures of adjacent monomers within the CTx B and
SLTx B pentamers. Monomers from CTx B (A) and SLTx B (B) viewed
either sideways (left) showing the interface region (dashed line) between
monomers or from the top (right) of the molecule. Structures colored to
indicate secondary structure (a-helix in red and b-sheet in yellow). Proposed
intermonomer interactions present in CTx B. The chain on the left is chain E;
the one on the right is chain D. Chain E is colored differently from D to
distinguish between the two. The critical residues in the intermonomer
interactions are picked out. E11/R35 are shown in standard atomic colors.
Residues involved in hydrophobic interactions are colored pink. The
hydrogen bond between E11 and R35 is shown, as is the disulphide bridge.
Image was made using ICM.
TABLE 1 Monomer-monomer interaction energies for the
CTx B and SLTx B pentamers*
Protein Bondy Bond energyz Protein Bond Bond energy
CTx B vdw 230.3 SLTx B vdw 123.9
(1fgb) hb 76.6 (1bov) hb 5.4
el 98.8 el 40.2
total§ 405.7 total 169.5
(236.2){
Gas phase stabilityk Gas phase stability
CTx B 45.1 SLTx B 28.1
(17.0)**
*Intersubunit interactions calculated from the x-ray structures (PDB codes)
and experimental gas phase dissociation data.
yBond type: vdw; van der Waals contact contribution (i.e., hydrophobic);
hb, hydrogen bond contribution; and el, electrostatic contribution (but not
including H-bond).
zBond energy calculated using Molsoft ICM program (kJ mol1).
§Total calculated energies associated with the monomer-monomer inter-
actions.
{Calculated energy difference between CTx B and SLTx B.
kExperimental energy derived from the center of mass collision energy
(kJ mol1).
**Experimental energy difference between CTx B and SLTx B.
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studied reside and function within an aqueous environment.
We believe that the data obtained in this study, however, are
highly relevant and informative, particularly since the pH
conditions used were near-physiological. As in our previous
study (37), data were obtained over a range of pH conditions
that correlates well with those encountered by the toxin
within the intestinal lumen during infection by V. cholerae.
Data for both the CTx AB5 holotoxin and the B5 pentamer
have demonstrated that the noncovalent interactions within
the toxin assemblies are maintained, and observable, under
both acidic and neutral conditions in the gas phase. Fur-
thermore, unlike the SLTxB5 pentamer, the CTxB5 pentamer
is stable at acidic pH, indicating that although the two related
pentamers share a similar fold at their b-sheet monomer-
monomer interfaces (50), additional interactions must be
present within the CTx B pentamer to account for its in-
creased stability. Since the initial stages of CTx mediated
cellular signaling are dependent on receptor oligomerization
after binding of the pentameric B chains, a rapid, sensitive
technique to examine the quaternary structure of both native
and any genetically engineered protein variants of CTx will
be beneﬁcial to further research performed on this toxin.
We thank Prof. Robert Freedman and Dr. Catherine Marsden for critical
reading, helpful discussion, and advice with the manuscript.
This study was supported by a Wellcome Trust program grant (063058/
Z/00/Z) to L.M.R.
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